These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8198382)

  • 1. Pathogenesis and host response in Pneumocystis carinii pneumonia.
    Su TH; Martin WJ
    Annu Rev Med; 1994; 45():261-72. PubMed ID: 8198382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar macrophage and glycoprotein responses to Pneumocystis carinii.
    Limper AH
    Semin Respir Infect; 1998 Dec; 13(4):339-47. PubMed ID: 9872631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages.
    Williams MD; Wright JR; March KL; Martin WJ
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):232-8. PubMed ID: 8845173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis of Pneumocystis carinii pneumonia.
    Gigliotti F; Wright TW
    Expert Rev Mol Med; 2005 Nov; 7(26):1-16. PubMed ID: 16842636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasitic adherence and host responses in the development of Pneumocystis carinii pneumonia.
    Limper AH
    Semin Respir Infect; 1991 Mar; 6(1):19-26. PubMed ID: 1887163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia.
    Hahn PY; Limper AH
    Semin Respir Infect; 2003 Mar; 18(1):40-7. PubMed ID: 12652453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis carinii: an atypical fungal micro-organism.
    Cailliez JC; Séguy N; Denis CM; Aliouat EM; Mazars E; Polonelli L; Camus D; Dei-Cas E
    J Med Vet Mycol; 1996; 34(4):227-39. PubMed ID: 8873881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.
    Roths JB; Sidman CL
    J Clin Invest; 1992 Aug; 90(2):673-8. PubMed ID: 1353767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
    Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
    J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytes in host defense against Pneumocystis carinii.
    Beck JM; Harmsen AG
    Semin Respir Infect; 1998 Dec; 13(4):330-8. PubMed ID: 9872630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages.
    Castro M; Morgenthaler TI; Hoffman OA; Standing JE; Rohrbach MS; Limper AH
    Am J Respir Cell Mol Biol; 1993 Jul; 9(1):73-81. PubMed ID: 8393326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of defence in the lung: lessons from Pneumocystis carinii pneumonia.
    Vassallo R; Thomas CF; Vuk-Pavlovic Z; Limper AH
    Sarcoidosis Vasc Diffuse Lung Dis; 2000 Jun; 17(2):130-9. PubMed ID: 10957761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.
    Lanken PN; Minda M; Pietra GG; Fishman AP
    Am J Pathol; 1980 Jun; 99(3):561-88. PubMed ID: 6966893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii: the art and science of survival in the hostile environment of the alveolar spaces.
    Martin WJ
    Semin Respir Infect; 1998 Dec; 13(4):348-52. PubMed ID: 9872632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral response in Pneumocystis carinii spontaneously infected rabbits.
    Ortona E; Visconti E; Barca S; Margutti P; Mencarini P; Zolfo M; Tamburrini E; Siracusano A
    J Eukaryot Microbiol; 1997; 44(6):49S. PubMed ID: 9508434
    [No Abstract]   [Full Text] [Related]  

  • 16. T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice.
    Beck JM; Blackmon MB; Rose CM; Kimzey SL; Preston AM; Green JM
    J Immunol; 2003 Aug; 171(4):1969-77. PubMed ID: 12902500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar macrophage interaction with Pneumocystis carinii.
    Koziel H; O'Riordan D; Warner A; Rose RM
    Immunol Ser; 1994; 60():417-36. PubMed ID: 8251584
    [No Abstract]   [Full Text] [Related]  

  • 18. Current insights into the biology and pathogenesis of Pneumocystis pneumonia.
    Thomas CF; Limper AH
    Nat Rev Microbiol; 2007 Apr; 5(4):298-308. PubMed ID: 17363968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar macrophage interactions with Pneumocystis carinii.
    Vassallo R; Thomas CF; Vuk-Pavlovic Z; Limper AH
    J Lab Clin Med; 1999 Jun; 133(6):535-40. PubMed ID: 10360627
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemical detection of Pneumocystis carinii in transbronchial lung biopsy specimens: antigen difference between human and rat Pneumocystis carinii.
    Kobayashi M; Moriki T; Uemura Y; Takehara N; Kubonishi I; Taguchi H; Miyoshi I
    Jpn J Clin Oncol; 1992 Dec; 22(6):387-92. PubMed ID: 1283992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.